FDA Approves Unknown Drug — TEVA PHARMS USA

TEVA PHARMS USA announced Tuesday it had received FDA approval for its generic version of this drug, setting the stage to compete in the niche market. The approval allows the company to capitalize on the precedent once the brand product expires, offering a patent-protected revenue stream.